GlassScriptPhysician profile
Michelle M Matarese
NPI 1316044266
$2,219.39
in general payments reported to CMS, 2019-2025
12 companies · $547 in 2025
The $547 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $532 · 2022: $480 · 2023: $419 · 2024: $241 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $562.67 | 2021-2025 | Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $500.57 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Mitris Resilia Mitral Valve |
| Boston Scientific Corporation | $341.78 | 2025 | Eluvia, Wavewriter Alpha Prime 16 |
| Saphena Medical, INC. | $237.00 | 2023 | Venapax |
| Getinge USA Sales, LLC | $138.06 | 2021-2025 | Heartstring III Proximal Seal |
| Medical Device Business Services, INC. | $121.20 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.92 | 2024-2025 | Lifevest |
| Haemonetics Corporation | $72.59 | 2025 | Teg6s Hemostasis System |
| Abbott Laboratories | $66.57 | 2022-2023 | Epic |
| Davol INC. | $44.00 | 2021 | |
| Ethicon US, LLC | $33.23 | 2021-2023 | Surgicel Nu-Knit |
| Abiomed | $27.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Matarese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.